Taro to Announce Second Quarter Results on October 28, 2020
October 22, 2020Earnings Call on Thursday, October 29th at 8:00 am ET
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020, on Wednesday, October 28, 2020.
The Company will conduct an earnings call at 8:00 am ET on Thursday, October 29, 2020, where senior management will discuss the Company’s performance and answer questions from participants.
The release will be accessible on Taro’s website at www.taro.com.
Earnings Call (8:00 am ET on Thursday, October 29, 2020)
To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.
Summary of events
|
Event |
Date and time |
Telephone number/ website |
|
Earnings release |
October 28, 2020 (AMC) |
|
|
Earnings conference call |
October 29, 2020 |
Participant Toll-Free Dial-In Number: +1 (844) 421-0601
Via audio webcast, details of which will be made available on www.taro.com |
|
Replay of conference call |
October 29, 2020 to |
+ 1 (855) 859-2056 or +1 (404) 537-3406
Via audio webcast playback, details of which will be made available on www.taro.com |
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
Contacts
Daphne Huang
VP, CFO
(914) 345-9001
[email protected]
William J. Coote
AVP, Treasurer and Investor Relations
(914) 345-9001
[email protected]